Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>DLBCL R/R*** > Treatment > USA. G. CAR T Therapy

---

USA. G. CAR T Therapy's subsections
(*) CN Approval Date: 2021. 06.23
(*) EU Approval Date: 2018. 08.27
(*) USA Approval Date: 2017. 10.18
Cell Therapy>Gene Therapy
Company
Company CN
Generic Name:
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2017. 10.18
TradeMark
TradeMark Web-Site

USA. G. CAR T Therapy's products
This section has no products